Most users who discontinue do so during the first 8 to 12 weeks when symptoms peak, which means preparing for this period can determine success
Constitutive activity of glucagon receptor mutants
This sets it apart from semaglutide (GLP-1 only) and tirzepatide (GLP-1 + GIP)
Citing a limitation of the study, scientists said the study cohort was restricted to privately insured US individuals, which may limit the generalisability of the findings to other populations
Common gastrointestinal adverse events experienced by some users include abdominal pain and stomach pain, in addition to nausea, diarrhea, heartburn, and indigestion
For general wellness or anti-aging, suggested amounts are typically 24 mg daily